ACS Applied Bio MaterialsBiophysicsPeer-reviewed journal article
MXene Protein Corona Interfaces for Molecular Profiling of Alzheimers Disease
Samantha VelazqueziD, Matthew C. JuberiD, Dalton Brindley, Anupma ThakuriD, Babak AnasoriiD, Edward LauiD, Ali Akbar AshkarraniD
Abstract
The protein corona (PC) that forms on the surface of nanomaterials upon contact with biological fluids provides a molecular snapshot of the hosts physiological and pathological state. Here, we investigate two-dimensional (2D) titanium carbide (Ti3C2Tx) MXene nanosheets as nanobiointerfaces for capturing Alzheimers disease (AD)-associated plasma protein signatures. Ti3C2Tx MXene flakes were incubated with plasma from clinically diagnosed AD patients and age-matched healthy controls (HC), leading to the formation of Ti3C2Tx MXene-PC complexes. Physicochemical characterization using dynamic light scattering, zeta potential analysis, and transmission electron microscopy revealed disease-dependent changes in hydrodynamic size, surface charge, and PC profile. Proteomic analysis of the isolated PC layers quantified 1,611 proteins without prior fractionation, demonstrating effective enrichment of low-abundance plasma components. Principal component analysis (PCA) revealed consistent separation between AD- and HC-derived Ti3C2Tx MXene-PC proteomes despite inter-individual heterogeneity. Differential abundance analysis identified selective enrichment of heterogeneous nuclear ribonucleoproteins (hnRNPs), annexins, and inflammatory mediators in AD-derived PC, implicating dysregulated RNA metabolism, membrane stress responses, and immune activation, hallmark processes in AD pathology. Our findings demonstrate that Ti3C2Tx MXene-PC interfaces act as selective molecular filters that reshape the detectable plasma proteome, enabling disease-associated molecular phenotyping and establishing a versatile nanointerface-driven framework for uncovering AD-related plasma signatures, providing a foundation for future translational diagnostic development.
- Citations
- 0
- FWCI
- 0.00
- Field percentile
- 23th percentile
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Deep nanoparticle protein corona plasma proteomics resolves a stage-specific peripheral signature of Alzheimer's disease
Negar Mahmoudi, Bahareh Ghaffari, … Morteza Mahmoudi·bioRxiv·Jul 28, 2026
- Global analysis of the heparin-enriched plasma proteome captures matrisome-associated proteins in Alzheimer's disease
Qi Jin Guo, Lingyan Ping, … Nicholas T. Seyfried·bioRxiv·Nov 6, 2023
- Interpretable Machine Learning Links Group-Specific Plasma Proteomics to Regional Structural Neuroimaging in Alzheimer's Disease
Hemshankar Laugi, Mohammadreza Hosseinzadehketilateh, … Xi Zhu·bioRxiv·Nov 4, 2026
- Mag-Net: Rapid enrichment of membrane-bound particles enables high coverage quantitative analysis of the plasma proteome
C. C. Wu, K. A. Tsantilas, … M. J. MacCoss·bioRxiv·Jun 10, 2023
- Proteomic identification and validation of novel neuronal EV-based markers for Alzheimers disease biomarker discovery
Waqar Ahmed, Carlos J. Nogueras‐Ortiz, … Vasiliki Mahairaki·bioRxiv·Apr 29, 2026
- Multi-Platform Proteomic Analysis of Alzheimer's Disease Cerebrospinal Fluid and Plasma Reveals Network Biomarkers Associated with Proteostasis and the Matrisome
Eric B. Dammer, Lingyan Ping, … Erik C. B. Johnson·Alzheimer s Research & TherapyPeer-reviewed·Nov 16, 2022